Glenmark Pharmaceuticals Ltd said that it has secured tentative approval from the US Food and Drug Administration (FDA) for Nintedanib Capsules, 100mg, and 150mg. Nintedanib Capsules is the generic version of Ofev Capsules (nintedanib), 100mg and 150mg, owned by Boehringer Ingelheim Pharmaceuticals. Ofev is approved to be used in patients with idiopathic pulmonary fibrosis (IPF), […]
Swedish pharma company Gesynta Pharma has reported positive results from the phase 1 clinical trial of GS-248, which is being developed for the treatment of microvascular diseases in chronic inflammatory conditions. The purpose of the early-stage clinical trial was to assess the safety, tolerability, pharmacokinetic and pharmacodynamic properties of GS-248 after subjecting healthy subjects to […]